Selective estrogen receptor modulator (SERM); induces regression of tamoxifen-resistant, hormone independent xenograft tumors. Displays no significant gain in uterine weight in treated mice.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 242.29. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||4.13 mL||20.64 mL||41.27 mL|
|5 mM||0.83 mL||4.13 mL||8.25 mL|
|10 mM||0.41 mL||2.06 mL||4.13 mL|
|50 mM||0.08 mL||0.41 mL||0.83 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Molloy et al (2014) Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancer. Mol.Cancer.Ther. 13 2515 PMID: 25205655
If you know of a relevant reference for BTC, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: oestrogen receptors modulators SERM tamoxifen resistant antitumor antitumour Estrogen and Related Receptors
Citations for BTC
Citations are publications that use Tocris products.
Currently there are no citations for BTC. Do you know of a great paper that uses BTC from Tocris? If so please let us know.